Basic Information
BOOSTRIX
50090-1377
Regulatory Information
50090-1377
BLA125106
C73585
March 31, 2025
USA
These highlights do not include all the information needed to use BOOSTRIX safely and effectively. See full prescribing information for BOOSTRIX. BOOSTRIX (Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, Adsorbed) injectable suspension, for intramuscular useInitial U.S. Approval: 2005
VACCINE LABEL
26
Company Information
830016429
Active Ingredients
Quantity: 5 [iU] in 0.5 mL
Code: K3W1N8YP13
Class Code: ACTIB
Quantity: 2.5 [iU] in 0.5 mL
Code: IRH51QN26H
Class Code: ACTIB
Quantity: 8 ug in 0.5 mL
Code: QSN5XO8ZSU
Class Code: ACTIB
Quantity: 8 ug in 0.5 mL
Code: 8C367IY4EY
Class Code: ACTIB
Quantity: 2.5 ug in 0.5 mL
Code: I05O535NV6
Class Code: ACTIB
ALUMINUM HYDROXIDE
Code: 5QB0T2IUN0
Class Code: IACT
FORMALDEHYDE
Code: 1HG84L3525
Class Code: IACT
SODIUM CHLORIDE
Code: 451W47IQ8X
Class Code: IACT
PEG-20 SORBITAN OLEATE
Code: 6OZP39ZG8H
Class Code: IACT
Active Moieties
CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED)
Code: K3W1N8YP13
CORYNEBACTERIUM DIPHTHERIAE TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED)
Code: IRH51QN26H
BORDETELLA PERTUSSIS TOXOID ANTIGEN (FORMALDEHYDE, GLUTARALDEHYDE INACTIVATED)
Code: QSN5XO8ZSU
BORDETELLA PERTUSSIS FILAMENTOUS HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED)
Code: 8C367IY4EY
BORDETELLA PERTUSSIS PERTACTIN ANTIGEN (FORMALDEHYDE INACTIVATED)
Code: I05O535NV6